Is Acadia Healthcare Company Inc (ACHC) a risky stock?
As of July 29, 2026, Clavix grades Acadia Healthcare Company Inc (ACHC) C- for risk, a composite score of 50 out of 100 on an A+ to F scale, which puts ACHC in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 29, 2026. Clavix regrades every trading day.
The five risk dimensions behind ACHC's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ACHC scores on each, as of July 29, 2026.
What's moving ACHC's risk right now
Company-specific signals Clavix flags behind ACHC's current grade, drawn from recent news and filings as of July 29, 2026.
A federal court denied Acadia's motion to dismiss a securities class action, letting the lawsuit move forward. ACHC now faces ongoing legal costs, management distraction, and the risk of damages if it ultimately loses.
Acadia's latest quarter topped EPS estimates by $0.03 with 7.6% revenue growth, yet the company still posted a negative net margin. Management's FY2026 outlook shows modest revenue upside, EPS roughly in line, and softer near-term guidance.
Recent ACHC news
The latest headlines Clavix ingested for Acadia Healthcare Company Inc, newest first. These feed the news-sentiment dimension of ACHC's grade.
-
Acadia Healthcare reported quarterly EPS of $0.38, beating analyst consensus estimates of $0.35 by $0.03, while revenue of $865.84M exceeded expectations of $844.19M. The company posted a positive return on equity of 7.09% alongside a negative net margin of 32.84%.
-
Robbins LLP is soliciting Acadia Healthcare (ACHC) stockholders to contact them for information about a class action lawsuit filed against the company. The article body contains no further details about the lawsuit's allegations, defendants, or filing details.
What a C- grade means
On the Clavix A+ to F scale, ACHC's composite of 50 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ACHC or any security. Grades are risk indicators, not predictions of return. Data may be delayed.